August 8, 2007 - CircuLite Inc. reported the launch of the clinical development program for its Synergy Pocket Circulatory Assist Device with the successful implantation of the first patient in a European feasibility trial, synergy is a miniature implantable blood pump, the size of a AA battery, that can be implanted superficially in a pocket, like a pacemaker.

August 8, 2007 – The FDA gave ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, clearance to market and sell the ZOLL AED Pro with See-Thru CPR technology, which is designed to help minimize interruptions in CPR, as ZOLL aims to comply with one of the key recommendations of the American Heart Association's (AHA) Guidelines for Advanced Cardiac Life Support.

August 8, 2007 – Emageon Inc. reported financial results for its second quarter ended June 30, 2007, reflecting net positive operating cash flow of $3.7 million for the second quarter of 2007, an improvement of $7.7 million over net negative operating cash flow of $4.0 million in first quarter 2007. For the six months ended June 30, 2007, net cash used in operations was $0.3 million. At June 30, 2007, cash and marketable securities totaled $20.9 million, compared to $23.0 million at December 31, 2006.

August 7, 2007 - The American College of Cardiology and the American Heart Association have jointly released revised Guidelines for the Management of Patients with Unstable Angina (UA)/Non-ST- Elevation Myocardial Infarction (NSTEMI).

August 7, 2007 – Doses of radiation can vary in pediatric coronary CTA, a heart-imaging test to detect fatty or calcium deposits in the coronary arteries, according to a study led by Caroline Hollingsworth, Duke University Medical Center, published in the American Journal of Roentgenology.

August 7, 2007 - Researchers found that a pulse-based system for screening older patients for atrial fibrillation to reduce risk of stroke is an effective approach.

In a study led by F.D. Richard Hobbs, M.B., Ch.B., of the University of Birmingham, UK, a team of researchers found that "opportunistic" screening by an irregular pulse, followed by electrocardiography (ECG), if needed, was as effective as systematic population screening and more sensitive than non-systematic case finding.

August 7, 2007 – After using a portable echocardiography to test the potential of B-type natriuretic peptide (BNP) assay in diagnosing heart failure among patients registered as having heart failure in a single primary care practice, researchers determined that BNP level is not useful for validating a primary care register diagnosis of heart failure, according to a report in the July 30th BMC Cardiovascular Disorders.

August 6, 2007 - Atrium Medical Corp., a manufacturer of chest drainage products, announced that its soft and firm thoracic catheters, PVC Catheters, are di-2-ethylhexyl phthalate (DEHP) free, in accordance with the FDA’s recommendation that medical device manufacturers reformulate products to remove DEHP.
Atrium remanufactured its catheters to not only in response the FDA’s push for medical device manufacturers to reformulate products to remove DEHP but also to support the recommendation by the FDA that all hospitals use alternatives to DEHP containing products.

August 6, 2007 - Boston Scientific Corp. announced that it will not move forward with a public offering of shares of its $1.4 billion surgical devices unit, which earns as much as a fifth of the company's sales, in a plan to reverse a drop in its share price.

August 6, 2007 - While the use of emergency angioplasty and clot-busting drugs to treat heart attack patients in the United States has increased significantly since the mid 1990s, about 10 percent of eligible patients still don't receive these therapies.

That's the finding of a new study in the American Journal of Medicine.

Angioplasty and clot-busting drugs reopen clogged arteries and restore blood flow to the heart muscle. This kind of treatment, called emergency reperfusion, can save lives and prevent lasting damage to the heart.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now